Eligiblity

First name

Atopic Dermatitis (Eczema) Study - 769/06Dec24

Any vaccine containing tetanus, diphtheria or pertussis (TdAP,Tetanus, TD)

I agree to Clinrol and TrialSearch using the data you have provided to identify the studies that may be best suited for you based on your conditions and location. By submitting your information, you agree to the Privacy Policy and Terms of Use and our processing of the information provided to fulfill your request for our services, including notifying you of customized study recommendations that are or become available, and to our sharing of your responses with the clinical trial doctor's office. You further understand that you may withdraw your consent at any time.

Eligibility

Eligible

Have you been diagnosed with Atopic Dermatitis, also known as eczema?

For how long have you been diagnosed with Atopic Dermatitis?

Does your eczema have any of the following characteristics? - Visible dull to bright redness - Red, raised patches - Itching or burning around the patches - Visible papules  - Thickening of the skin - Leathery appearance of the skin - Oozing or crusting

Taking into account all of your eczema lesions, does your eczema cover more than 10% of your body? For reference, this should be the size of 10 palm prints or more.

Has a doctor recommended treatment with a topical, oral or injectable medication for your eczema in the last 6 months?

Have you had either of the following vaccine types in the last 5 years?

Would you be willing to receive pneumococcal and tetanus vaccinations as a condition of study participation?

Have you ever used/taken any of the following medications for your eczema? - Ruxolitinib (Opzelura) – cream/oral - Abrocitinib (Cibinqo) – oral - Baricitinib – oral - Tofacitinib (Xeljanz) – oral - Upadacitinib (Rinvoq) – oral

Have you used the following medications within the last 6 months? - Rituxan (Rituximab) - Kesimpta (Ofatumumab)

Have you ever been diagnosed with or treated for any type of cancer (other than resolved skin or cervical cancer)?

Are you currently participating in another clinical study?